Safety and Efficacy of APG-157 in Head and Neck Cancer

Summary

The purpose of this clinical research study is to study safety and efficacy of orally administered APG-157 as the neoadjuvant/induction therapy in newly diagnosed, locally advanced patients with Head \& Neck Cancer of oral cavity and/or oropharynx. The study hypothesis is that neoadjuvant use of APG-157 will reduce the tumor burden prior to any definitive therapy to improve the outcomes over current standard of care.

Timeline

Start

2022-04-22

Primary completion

2026-12

Completion

2026-12

Drugs

Indications